Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Macrophage ferritin heavy chain/α-synuclein regulatory axis modulates ferroptosis during kidney injury
Tanima Chatterjee, Sarah Machado, Kellen Cowen, Mary E. Miller, Bronte Johnson, Yanfeng Zhang, Laura A. Volpicelli-Daley, Lauren A. Fielding, Rudradip Pattanayak, Frida Rosenblum, László Potor, György Balla, Jozsef Balla, Christian Faul, Abolfazl Zarjou
Tanima Chatterjee, Sarah Machado, Kellen Cowen, Mary E. Miller, Bronte Johnson, Yanfeng Zhang, Laura A. Volpicelli-Daley, Lauren A. Fielding, Rudradip Pattanayak, Frida Rosenblum, László Potor, György Balla, Jozsef Balla, Christian Faul, Abolfazl Zarjou
View: Text | PDF
Research Article Immunology Nephrology

Macrophage ferritin heavy chain/α-synuclein regulatory axis modulates ferroptosis during kidney injury

  • Text
  • PDF
Abstract

Macrophages, endowed with remarkable phenotypic plasticity, are essential for orchestrating injury responses and regulating iron homeostasis. Given the central role of ferritin heavy chain (FtH) as a molecular rheostat linking iron sequestration to redox-dependent signaling, we examined how myeloid FtH governs renal iron trafficking and ensuing oxidative stress pathways during acute kidney injury (AKI). Transcriptome analysis revealed coupling of FtH deficiency in monocytes and macrophages with activation of ferroptosis, a regulated cell death associated with iron accumulation. Moreover, myeloid FtH deletion worsened AKI, increasing leukocyte infiltration and iron deposition, together with ferroptosis-associated gene induction, oxidative stress, and lipid peroxidation. Notably, α-synuclein (SNCA), an iron-binding protein and the main pathological driver of Parkinson’s disease, was robustly induced both by FtH deficiency and following AKI. Mechanistic studies showed that monomeric SNCA exhibits ferrireductase activity, amplifying redox cycling and promoting ferroptotic cell death. Furthermore, SNCA expression was elevated in kidney pathologies characterized by leukocyte expansion in both mouse models and human cohorts, suggesting that inflammatory microenvironments promote SNCA accumulation and redox imbalance. These findings define a macrophage FtH/SNCA regulatory axis as a key driver of ferroptosis in AKI, implicating SNCA as a pathological nexus between iron dyshomeostasis and inflammatory kidney injury.

Authors

Tanima Chatterjee, Sarah Machado, Kellen Cowen, Mary E. Miller, Bronte Johnson, Yanfeng Zhang, Laura A. Volpicelli-Daley, Lauren A. Fielding, Rudradip Pattanayak, Frida Rosenblum, László Potor, György Balla, Jozsef Balla, Christian Faul, Abolfazl Zarjou

×

Figure 3

Single-cell transcriptomic analysis of leukocytes reveals ferroptosis induction following FtH deletion.

Options: View larger image (or click on image) Download as PowerPoint
Single-cell transcriptomic analysis of leukocytes reveals ferroptosis in...
(A) Schematic of the experimental setup. FtHfl/fl and FtHΔ/Δ mice received vehicle or AA for 5 consecutive days. Mice were harvested for scRNA-seq analysis of kidney leukocytes 6 weeks after vehicle or AA administration. H, harvest and endpoint analysis. (B) UMAP plot showing the clustering of immune cells (CD45+) in the kidney based on scRNA-seq. The analysis identifies 9 distinct clusters, with contaminating kidney cells and clusters representing less than 1% removed. (C) Cell type–specific expression of marker genes for manually annotated clusters. Dot size denotes percentage of cells expressing the marker. Color scale represents average gene expression values. (D) Pathway enrichment analysis of differentially expressed genes in FtH-deficient cells versus WT cells under vehicle-treated conditions. (E) Pathway enrichment analysis of differentially expressed genes in FtH-deficient cells versus WT cells following AA administration. (F and G) Gene set enrichment analysis (GSEA) for glutathione metabolism (F) and ferroptosis (G) pathways in monocytes/macrophages from vehicle- and AA-treated FtHfl/fl and FtHΔ/Δ mice. The size of the dots represents the percentage of genes enriched in the pathway, while the color indicates the z score. (H) Dot plot showing key genes involved in ferroptosis across different genotypes and experimental conditions. Dot size denotes percentage of cells expressing the marker. Color scale represents average gene expression values.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts